Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion

Melanoma live: Making patient-focused therapy decisions

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies

Quality of life and cost advantages of metronomics and drug repurposing

Industry view of targeted therapy combinations in oncology

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care

Work of the WIN consortium and challenges of personalised cancer therapy

Combining immunological and targeted agents in melanoma

Novel drug targets and potential combinations in childhood brain tumours

Philadelphia chromosome and the role it plays in chronic myeloid leukaemia

Novel targeting in acute myeloid leukaemia